ストックスクリーナーアプリを入手
1.99
4.76%
-0.11
前日終値:
$2.10
開ける：
$2.1
24時間の取引高:
953.45K
Relative Volume:
0.56
時価総額：
$558.86M
収益：
-
当期純損益:
$-208.38M
株価収益率:
-1.6583
EPS:
-1.2
ネットキャッシュフロー:
$-156.57M
1週間 パフォーマンス:
-9.50%
1か月 パフォーマンス:
-20.63%
6か月 パフォーマンス:
-50.25%
1年 パフォーマンス:
-68.35%
1日の値動き範囲:
$1.99
$2.13
1週間の範囲:
$1.99
$2.23
52週間の値動き範囲:
$1.99
$7.37
Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile
AUTL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AUTL
Autolus Therapeutics Plc Adr
|
1.99 | 558.86M | 0 | -208.38M | -156.57M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.79 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
716.90 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
652.50 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.13 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.43 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-18 | アップグレード | Goldman | Neutral → Buy |
| 2024-11-15 | アップグレード | Redburn Atlantic | Neutral → Buy |
| 2023-11-09 | 開始されました | Deutsche Bank | Buy |
| 2023-03-27 | 再開されました | Wells Fargo | Overweight |
| 2023-03-17 | 開始されました | Bryan Garnier | Buy |
| 2021-06-14 | アップグレード | Jefferies | Hold → Buy |
| 2021-01-29 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-12-28 | 再開されました | H.C. Wainwright | Buy |
| 2020-07-31 | 開始されました | JP Morgan | Overweight |
| 2020-07-22 | 開始されました | SunTrust | Buy |
| 2020-04-22 | 開始されました | Mizuho | Buy |
| 2019-09-23 | 開始されました | Needham | Buy |
| 2019-05-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-10-24 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Autolus Therapeutics Plc Adr (AUTL) 最新ニュース
There is no doubt that Nurix Therapeutics Inc (NRIX) ticks all the boxes. - SETE News
Enovis Corp (ENOV) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
Check Out TC BioPharm (Holdings) plc ADR (TCBP)’s Trade Data Rather Than the Analysts’ Views - SETE News
You might want to take a look at Autolus Therapeutics plc ADR (AUTL) now - SETE News
Clean Energy Fuels Corp (CLNE)’s stock rises to 3.45 per share - US Post News
Adc Therapeutics SA (ADCT) stock analysis: A comprehensive overview - US Post News
GH Research PLC (GHRS) stock: A year of ups and downs - US Post News
Calumet Inc (CLMT)’s stock price range in the last year - US Post News
A closer look at Autolus Therapeutics plc ADR (AUTL)’s stock price trends - US Post News
Quarterly Snapshot: Quick and Current Ratios for Autolus Therapeutics plc ADR (AUTL) - The Dwinnex
Balance Sheet Insights: Edison International (EIX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Selling Your Standard Lithium Ltd (AMEX: SLI) Stock? Here’s What You Need To Know - Stocks Register
Autolus presents new data on CAR-T therapy cost benefits - Investing.com
Autolus' AUCATZYL Shows Superior Cost-Effectiveness and 84% Deep Remission Rate in Latest Data - StockTitan
A Stock Analysis Of Autolus Therapeutics plc ADR’s (AUTL) - Stocks Register
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 - GlobeNewswire Inc.
MicroAlgo Inc’s (MLGO) -2.91% Drop Is A Reason To Reconsider. - Stocks Register
Aspen Aerogels Inc (ASPN) Strikes $14.34: The Risk Seems Worthwhile At This Price - Stocks Register
Autolus reports high response in leukemia study - Investing.com India
CommScope Holding Company Inc (COMM) Is A Good Investment At Current Valuations - Stocks Register
Autolus Therapeutics plc ADR (AUTL) Has A Gold Mine On Its Hands - Stocks Register
These Numbers Prove Just How Vibrant The Ocugen Inc (NASDAQ: OCGN) Stock Has Been - Stocks Register
Autolus stock upgraded as obe-cel approval drives optimism for commercial potential - Investing.com
Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 - Barchart
Does MP Materials Corporation (NYSE: MP) Still Need To Convince Analysts? - Stocks Register
Hafnia Ltd (NYSE: HAFN) Drops -3.00%, Turning Investors Away - Stocks Register
Autolus Therapeutics (AUTL): High-Growth UK Stock in Cancer Therapy - Yahoo Finance
Why Autolus Therapeutics plc (AUTL) is the Penny Stock with the Biggest Upside Potential According to Analysts - Yahoo Finance
PDD Holdings Inc ADR (NASDAQ: PDD) Has Been Trading Down. What Are The Prospects For The Future? - Stocks Register
What Do Wall Street Analysts Think About Moderna Inc (NASDAQ: MRNA) Stock? - Stocks Register
Before You Invest, Make Sure You Check This Autolus Therapeutics plc ADR (NASDAQ: AUTL) Analysis - Stocks Register
Autolus Therapeutics plc ADR (AUTL)’s stock rises to 4.14 per share - US Post News
Autolus Therapeutics plc ADR: -44.83% Growth from 52-Week Low, Yet Analysts Divided - The InvestChronicle
A better buy-in window may exist right now for Autolus Therapeutics plc ADR (AUTL) - SETE News
Upward Trajectory: Autolus Therapeutics plc ADR (AUTL) Posts a Slidee, Closing at 3.98 - The Dwinnex
Autolus Therapeutics plc ADR (AUTL) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Are Smart Investors Making the Right Decision? Autolus Therapeutics plc ADR (AUTL) - SETE News
Autolus Therapeutics plc ADR (AUTL) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Autolus Therapeutics plc ADR (AUTL)’s stock chart: A technical perspective - US Post News
Stock Performance Spotlight: Autolus Therapeutics plc ADR (AUTL) Ends the Day at 3.63, Up by 4.31 - The Dwinnex
A look into Autolus Therapeutics plc ADR (AUTL)’s deeper side - SETE News
Are Autolus Therapeutics plc ADR (AUTL) shares a good deal now? - US Post News
Autolus Therapeutics plc ADR (AUTL)’s Market Momentum: Closing Strong at 3.73, Down -3.12 - The Dwinnex
Autolus Therapeutics (NASDAQ:AUTL) Shares Down 4.8% - MarketBeat
Autolus Therapeutics names new Chief Development Officer - Investing.com India
Autolus Therapeutics names new Chief Development Officer By Investing.com - Investing.com South Africa
Autolus Therapeutics plc (NASDAQ:AUTL) Short Interest Down 8.0% in August - Defense World
Autolus Therapeutics plc ADR (AUTL) looking to reclaim success with recent performance - SETE News
Autolus Therapeutics plc ADR (AUTL) Stock: Navigating a Year of Volatility - The InvestChronicle
Autolus Therapeutics plc (NASDAQ:AUTL) Shares Acquired by Daiwa Securities Group Inc. - Defense World
Autolus Therapeutics plc ADR (AUTL)’s stock price in review: A technical analysis - US Post News
Autolus Therapeutics Plc Adr (AUTL) 財務データ
収益
当期純利益
現金流量
EPS
1.47%
大文字化:
|
ボリューム (24 時間):